Mostrar el registro sencillo del ítem

dc.contributorFacultad de Veterinariaes_ES
dc.contributor.authorDe Nova, Pedro J. G.
dc.contributor.authorCarvajal Urueña, Ana María 
dc.contributor.authorPrieto Maradona, Miguel 
dc.contributor.authorRubio Nistal, Pedro Miguel 
dc.contributor.otherSanidad Animales_ES
dc.date2019
dc.date.accessioned2024-04-03T07:34:45Z
dc.date.available2024-04-03T07:34:45Z
dc.identifier.citationDe Nova, P. J. G., Carvajal, A., Prieto, M., & Rubio, P. (2019). In vitro susceptibility and evaluation of techniques for understanding the mode of action of a promising non-antibiotic citrus fruit extract against several pathogens. Frontiers in Microbiology, 10(APR), Article e884. https://doi.org/10.3389/FMICB.2019.00884es_ES
dc.identifier.otherhttps://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.00884/fulles_ES
dc.identifier.urihttps://hdl.handle.net/10612/19334
dc.descriptionCopyright © 2019 de Nova, Carvajal, Prieto and Rubio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.es_ES
dc.description.abstract[EN] The screening for alternatives to antibiotics is an urgent need for the pharmaceutical industry. One of these alternatives seems to be the citrus fruit extracts, which are showing a significant antibacterial activity against Gram-negative and Gram-positive bacteria. One of these citrus extracts, named BIOCITRO®, is assessed in this study to elucidate its bacteriostatic and bactericidal effect and its mode of action on the important pathogens Campylobacter coli, C. jejuni, Escherichia coli, Salmonella enterica ssp. enterica, Clostridium difficile, C. perfringens, and Staphylococcus aureus. For most of the strains tested of these bacteria the product was bactericidal as well as bacteriostatic at the same concentration, and the minimum bactericidal concentrations ranged from 16 to 256 μg/mL. Regarding the mode of action, important changes in the permeability, structure, composition and morphology of the bacterial envelope were evidenced using flow cytometry, Fourier transform infrared spectroscopy and scanning electron microscopy. The main effect of the product was found over carbohydrates and polysaccharides, inducing the release of microvesicles by the cells in addition to other specific effects. During the study, the techniques used were evaluated to clarify their contribution to the knowledge of the mode of action of the product. The survival test elucidated whether the modifications displayed using other techniques affected the viability of the cells or on the contrary, the cells remained viable even with evident changes in their structure, composition or morphology. Flow cytometry showed that for some strains the proportion of cells detected with altered membrane permeability were higher than the number of non-viable cells, and therefore the damage did not affect the viability of some cells. On the contrary, some cells observed using scanning electron microscopy with no apparent damage, were demonstrated non-viable using the survival test, making this technique indispensable in studies of the mode of action of antimicrobials to make a correct interpretation of the data from other techniques.es_ES
dc.languageenges_ES
dc.publisherFrontiers Mediaes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectFarmacologíaes_ES
dc.subjectSanidad animales_ES
dc.subject.otherNon-antibiotic citrus fruit extractes_ES
dc.subject.otherGram-positive bacteriaes_ES
dc.subject.otherGram-negative bacteriaes_ES
dc.subject.otherPharmaceutical industryes_ES
dc.titleIn vitro Susceptibility and Evaluation of Techniques for Understanding the Mode of Action of a Promising Non-antibiotic Citrus Fruit Extract Against Several Pathogenses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.3389/FMICB.2019.00884
dc.description.peerreviewedSIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1664-302X
dc.journal.titleFrontiers in Microbiologyes_ES
dc.volume.number10es_ES
dc.page.initial884es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.unesco2414.01 Antibióticoses_ES
dc.subject.unesco3108.01 Bacteriases_ES
dc.subject.unesco3209 Farmacologíaes_ES
dc.description.projectThe research was partly financed by PROBENA (2015/00119/001), the company commercializing BIOCITRO® in the EU, but without any influence over the experimental procedures neither results.es_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional